Biophysics and Clinical Effectiveness of Irreversible Electroporation for Catheter Ablation of Atrial Fibrillation by Anna-Sophie Eberl, Gernot Plank, Martin Manninger, Ursula Rohrer, Laura Stix, Stefan Kurath-Koller, Andreas Zirlik, Daniel Scherr

Get full text

Sirtuin 4 accelerates heart failure development by enhancing reactive oxygen species-mediated profibrotic transcriptional signaling by Nikole J. Byrne, Christoph Koentges, Elisabeth Khan, Katharina Pfeil, Robert Sandulescu, Sayan Bakshi, Carolin Költgen, Ivan Vosko, Johannes Gollmer, Thomas Rathner, Günter Roth, Michael M. Hoffmann, Katja E. Odening, Hauke Horstmann, Luke A. Potter, Christoph Bode, Dennis Wolf, Harald Sourij, Senka Ljubojevic-Holzer, Markus Wallner, Peter P. Rainer, Simon Sedej, Daniel Scherr, Dirk von Lewinski, Adam R. Wende, Andreas Zirlik, Heiko Bugger

Get full text

Anticoagulation in Patients With Device‐Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH‐AFNET 6 Trial by Hans Christoph Diener, Nina Becher, Susanne Sehner, Tobias Toennis, Emanuele Bertaglia, Carina Blomstrom‐Lundqvist, Axel Brandes, Vincent Beuger, Melanie Calvert, A. John Camm, Gregory Chlouverakis, Gheorghe‐Andrei Dan, Wolfgang Dichtl, Alexander Fierenz, Andreas Goette, Joris R. de Groot, Astrid Hermans, Gregory Y. H. Lip, Andrzej Lubinski, Eloi Marijon, Béla Merkely, Lluís Mont, Julius Nikorowitsch, Ann‐Kathrin Ozga, Kim Rajappan, Andrea Sarkozy, Daniel Scherr, Renate B. Schnabel, Ulrich Schotten, Emmanuel Simantirakis, Panos Vardas, Dan Wichterle, Antonia Zapf, Paulus Kirchhof

Get full text